| 275) n can be used in the development of novel treatment approaches for the COVID-19 pand |
| 276) (NMA) allows the comparison of different treatment approaches in a single, systemat |
| 277) eoperative predictors, and preventive and treatment approaches including behavioral, |
| 278) st in developing effective and innovative treatment approaches to manage and improve |
| 279) Many conservative treatment methods for neck pain have been |
| 280) lts of trials that investigated different treatment methods for neglect syndrome. |
| 281) d analyzes three or more interventions or treatment methods using both direct and in |
| 282) sments were used in these studies, and 17 treatment methods were applied. |
| 283) ough evidence to confirm this as a viable treatment option for COVID-19. |
| 284) nerve stimulation (HNS) is an alternative treatment option for obstructive sleep apn |
| 285) stands as a precious non-pharmacological treatment option for patients with IIM. |
| 286) f-concept results, before NIBS could be a treatment option to improve limb apraxia i |
| 287) Treatment options, however, remain scarce, |
| 288) h care providers, cultural sensitivity of treatment options, and cultural accessibil |
| 289) In addition to pharmacological treatment options, non-pharmacological met |
| 290) f fly control measures, non-antimicrobial treatment options, the continued search fo |
| 291) ive tool for measuring the uncertainty of treatment ranking by improving the transla |
| 292) can be used to compare the uncertainty of treatment ranking within a network meta-an |
| 293) network meta-analyses have overemphasized treatment ranking without paying attention |
| 294) refined interpretation of uncertainty of treatment ranking. |
| 295) ound: Adherence to and the maintenance of treatment regimens are fundamental for pai |
| 296) Therefore, to design better treatment regimens for TB, we need to unde |
| 297) lled trials (RCTs) evaluating 5 different treatment regimens for genitourinary syndr |
| 298) All treatment regimens had comparable efficacy |
| 299) ettings for screening patients to improve treatment strategies in cervical cancer. |
| 300) or juxtaposing molecular subtype targeted treatment strategies with the adjuvant use |
| 301) and provides future insights for clinical treatment strategies. |
| 302) development of preclinical testing of new treatment strategies. |
| 303) Age, diet, disease state, and treatment adherence also influence drug re |
| 304) of interpersonal coordination to improve treatment adherence and reduce stigma, as |
| 305) oviral therapy and two explored issues of treatment adherence. |
| 306) osis and could help to develop an optimal treatment approach by an early detection. |
| 307) de effect profile of these AEDs, a recent treatment approach involves priority use o |
| |